Baker Brothers Life Sciences Capital (GP), LLC
Insider CIK 1307729 · SGEN Director, 10% owner · ADLR 10% owner · RDEA Director, 10% owner · GHDX Director, 10% owner · TZYM 10% owner · INCY Director, 10% owner · GEVA Director, 10% owner · PCYC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TZYM TRANZYME INC | P Buy | 2012-03-14 | 2012-03-14 | 56,294 | $2.99 | $168.3K | 3,505,471 | SEC↗ |
| TZYM TRANZYME INC | P Buy | 2012-03-14 | 2012-03-14 | 34,544 | $3.01 | $104.0K | 3,540,015 | SEC↗ |
| TZYM TRANZYME INC | P Buy | 2012-03-13 | 2012-03-14 | 159,015 | $2.96 | $470.7K | 3,449,177 | SEC↗ |
| TZYM TRANZYME INC | P Buy | 2012-03-12 | 2012-03-14 | 572,737 | $2.55 | $1.46M | 3,290,162 | SEC↗ |
| TZYM TRANZYME INC | P Buy | 2012-03-12 | 2012-03-14 | 327,769 | $2.34 | $767.0K | 2,717,425 | SEC↗ |
| TZYM TRANZYME INC | P Buy | 2012-03-12 | 2012-03-14 | 44,467 | $1.87 | $83.2K | 2,389,656 | SEC↗ |
| TZYM TRANZYME INC | P Buy | 2012-03-12 | 2012-03-14 | 16,326 | $1.89 | $30.9K | 2,345,189 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-03-08 | 2012-03-09 | 19,513 | $30.36 | $592.4K | 8,255,421 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-03-07 | 2012-03-09 | 22,071 | $29.88 | $659.5K | 8,235,908 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-03-05 | 2012-03-05 | 85,231 | $29.96 | $2.55M | 8,144,054 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-03-05 | 2012-03-05 | 69,783 | $30.07 | $2.10M | 8,213,837 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-03-02 | 2012-03-05 | 91,459 | $29.52 | $2.70M | 8,058,823 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-03-01 | 2012-03-05 | 15,288 | $29.47 | $450.5K | 7,967,364 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-29 | 2012-02-29 | 156,902 | $29.06 | $4.56M | 7,952,076 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-28 | 2012-02-29 | 51,248 | $29.11 | $1.49M | 7,795,174 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-27 | 2012-02-29 | 36,881 | $29.03 | $1.07M | 7,743,926 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-23 | 2012-02-23 | 62,098 | $28.12 | $1.75M | 7,707,045 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-22 | 2012-02-23 | 5,511 | $27.98 | $154.2K | 7,644,947 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-21 | 2012-02-23 | 46,909 | $27.98 | $1.31M | 7,639,436 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-16 | 2012-02-16 | 91,543 | $29.85 | $2.73M | 7,592,527 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-16 | 2012-02-16 | 93,088 | $29.61 | $2.76M | 7,500,984 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-16 | 2012-02-16 | 349 | $28.96 | $10.1K | 7,407,896 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-15 | 2012-02-16 | 32,125 | $28.88 | $927.8K | 7,407,547 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-14 | 2012-02-16 | 55,804 | $28.44 | $1.59M | 7,375,422 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-10 | 2012-02-10 | 112,735 | $26.60 | $3.00M | 7,272,521 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-10 | 2012-02-10 | 28,469 | $26.52 | $755.0K | 7,319,618 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-10 | 2012-02-10 | 18,628 | $26.62 | $495.9K | 7,291,149 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-09 | 2012-02-10 | 3,883 | $26.24 | $101.9K | 7,159,786 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-09 | 2012-02-10 | 49,670 | $26.33 | $1.31M | 7,155,903 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-09 | 2012-02-10 | 2,441 | $26.27 | $64.1K | 7,106,233 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-08 | 2012-02-10 | 60,315 | $26.26 | $1.58M | 7,103,792 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-08 | 2012-02-10 | 135,681 | $26.18 | $3.55M | 7,043,477 | SEC↗ |
| GHDX GENOMIC HEALTH INC | P Buy | 2012-02-08 | 2012-02-10 | 6,093 | $26.17 | $159.5K | 6,907,796 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | P Buy | 2012-02-01 | 2012-02-03 | 876,828 | $17.00 | $14.91M | 4,922,226 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-26 | 2012-01-26 | 75,149 | $17.89 | $1.34M | 8,574,445 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-26 | 2012-01-26 | 168,641 | $17.95 | $3.03M | 8,499,296 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-25 | 2012-01-26 | 17,571 | $18.43 | $323.8K | 8,330,655 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-25 | 2012-01-26 | 107,980 | $18.55 | $2.00M | 8,313,084 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-24 | 2012-01-26 | 85,169 | $18.01 | $1.53M | 8,205,104 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-24 | 2012-01-26 | 46,142 | $17.86 | $824.1K | 8,119,935 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-23 | 2012-01-23 | 43,644 | $16.90 | $737.6K | 7,955,222 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-23 | 2012-01-23 | 72,997 | $16.88 | $1.23M | 8,028,219 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-23 | 2012-01-23 | 45,574 | $16.84 | $767.5K | 8,073,793 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy deriv | 2012-01-20 | 2012-01-23 | 87 | $1.50 | $131 | 249 | SEC↗ |
| PCYC PHARMACYCLICS INC | X Exercise deriv | 2012-01-20 | 2012-01-23 | 162 | $1.25 | $203 | 87 | SEC↗ |
| PCYC PHARMACYCLICS INC | X Exercise deriv | 2012-01-20 | 2012-01-23 | 87 | $1.50 | $131 | 0 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-20 | 2012-01-23 | 178,921 | $16.41 | $2.94M | 7,817,433 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-20 | 2012-01-23 | 69,245 | $16.43 | $1.14M | 7,886,678 | SEC↗ |
| PCYC PHARMACYCLICS INC | X Exercise | 2012-01-20 | 2012-01-23 | 16,200 | $15.00 | $243.0K | 7,902,878 | SEC↗ |
| PCYC PHARMACYCLICS INC | X Exercise | 2012-01-20 | 2012-01-23 | 8,700 | $15.00 | $130.5K | 7,911,578 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy deriv | 2012-01-19 | 2012-01-23 | 162 | $1.25 | $203 | 162 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-19 | 2012-01-23 | 10,327 | $16.07 | $166.0K | 7,636,063 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-19 | 2012-01-23 | 2,449 | $15.81 | $38.7K | 7,638,512 | SEC↗ |
| PCYC PHARMACYCLICS INC | P Buy | 2012-01-19 | 2012-01-23 | 22,081 | $16.07 | $354.8K | 7,625,736 | SEC↗ |
| INCY INCYTE CORP | P Buy | 2012-01-13 | 2012-01-17 | 102,856 | $16.46 | $1.69M | 12,316,128 | SEC↗ |
| INCY INCYTE CORP | P Buy | 2012-01-13 | 2012-01-17 | 72,978 | $16.58 | $1.21M | 12,389,106 | SEC↗ |
| INCY INCYTE CORP | P Buy | 2012-01-13 | 2012-01-17 | 41,677 | $16.62 | $692.7K | 12,430,783 | SEC↗ |
| INCY INCYTE CORP | P Buy | 2012-01-12 | 2012-01-17 | 105,847 | $16.38 | $1.73M | 11,993,391 | SEC↗ |
| INCY INCYTE CORP | P Buy | 2012-01-12 | 2012-01-17 | 219,881 | $16.21 | $3.56M | 12,213,272 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2012-01-05 | 2012-01-09 | 1,077,225 | $25.18 | $27.12M | 5,077,676 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | X Exercise deriv | 2011-12-30 | 2012-01-04 | 355,143 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | X Exercise | 2011-12-30 | 2012-01-04 | 355,143 | $6.25 | $2.22M | 15,131,223 | SEC↗ |
| ADLR ADOLOR CORP | U Tender | 2011-12-19 | 2012-01-03 | 6,669,338 | $4.25 | $28.34M | 0 | SEC↗ |